It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2019.
2019 | Indore, Madhya Pradesh, India | ActiveXena Formulations Private Limited, a active private limited company, was established on 16 December 2019 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MP2019PTC050369. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Ritesh Sohgaura (Director), Bipin Kumar Pandey (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 151 Swami Dayanand Nagar, Indore, Madhya Pradesh, 452009.
U24230MP2019PTC050369
050369
16 December 2019
₹1.50 M
₹0.50 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Xena Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ritesh Sohgaura | Director | 16 Dec 2019 | Current |
| Bipin Kumar Pandey | Director | 16 Dec 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Xena Formulations Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 54.76% decrease in profit. The company's net worth dipped by a decrease of 7.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Xena Formulations had a public holding of 22.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Xena Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Xena Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xena Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Xena Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Xena Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was documented.
The activity Ritesh Sohgaura was appointed as a Director was appointed as a Director on 16 Dec 2019 & has been associated with this company since 6 years 2 days . was completed.
The activity Bipin Kumar Pandey was appointed as a Director was appointed as a Director on 16 Dec 2019 & has been associated with this company since 6 years 2 days . was completed.
The activity Xena Formulations Private Limited was registered on 16 Dec 2019 with Roc Gwalior & aged 6 years 2 days as per MCA records. was completed.
The CIN of Xena Formulations Private Limited is U24230MP2019PTC050369.
Xena Formulations Private Limited is headquartered at 151 Swami Dayanand Nagar, Indore, Madhya Pradesh, 452009.
Xena Formulations Private Limited was incorporated on 16 December 2019.
The current directors of Xena Formulations Private Limited are
The primary industry of Xena Formulations Private Limited is Pharma.
Xena Formulations Private Limited is unlisted.
The authorized capital of Xena Formulations Private Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX